Compounding Pharmacy Draws Warning Letter for Misbranded, Unapproved Drugs

The FDA Philadelphia district office has issued a warning letter to a compounding pharmacy in Allentown, PA over misbranded drugs and sterility issues.
Source: Drug Industry Daily